In September, Indian drug manufacturer Alembic received a tentative nod from the US Food and Drug Administration (FDA) to manufacture generic alogliptin as well as the alogliptin/metformin fixed-drug ...
The effect of DPP-4 inhibitors on heart failure in diabetes patients is uncertain. Current evidence is inadequate to determine how DPP-4 inhibitors affect the risk of heart failure in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results